Navidea Biopharmaceutical...

0.00
null (null%)
At close: Jan 16, 2025, 8:00 PM
0.00
900.00%
Pre-market Sep 03, 2024, 09:30 AM EDT

Navidea Biopharmaceuticals Inc. Revenue Breakdown

Quarter Dec 31, 2022Sep 30, 2022Dec 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Mar 31, 2019Dec 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Corporate Segment Revenue 0 7.52K 50.35K 188.93K 113.50K 8.92K 74.14K 94.41K 5.50K 315.14K 210.48K 518.38K 571.36K 10.28M 6.45M 5.66M 8.24M 5.01M 0 0
Corporate Segment Revenue Growth -100.00% -85.07% -73.35% +66.45% +1172.44% -87.97% -21.47% +1614.95% -98.25% +49.73% -59.40% -9.27% -94.44% +59.32% +13.99% -31.31% +64.67% n/a n/a n/a
Diagnostics Segment Revenue 610 0 0 30.32K 154.89K n/a 82.14K 39.14K 44.11K 80.00K 13.19K 93.22K 8.67K 20.69K 102.90K n/a n/a n/a 0 0
Diagnostics Segment Revenue Growth n/a n/a -100.00% -80.42% n/a n/a +109.84% -11.27% -44.86% +506.50% -85.85% +975.50% -58.11% -79.89% n/a n/a n/a n/a n/a n/a
Therapeutics Segment Revenue 0 0 0 n/a n/a n/a n/a 2.48K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Therapeutics Segment Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2015
Non Us Revenue 24.69K
Non Us Revenue Growth n/a
U S Revenue 10.23M
U S Revenue Growth n/a

Operating Expense Breakdown

Quarter Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 1.30M 1.32M 1.15M 1.26M 3.64M 1.26M 1.81M 2.32M 1.47M 1.43M 2.23M 1.75M 1.79M 1.33M 1.83M 1.17M 1.52M 1.86M 1.82M 1.44M 2.69M 1.79M 1.78M 2.16M 1.73M 4.25M 3.02M 3.09M 2.94M 2.89M 4.10M 3.77M 3.94M 4.05M 5.49M
Selling, General, and Administrative Revenue Growth -1.49% +14.42% -8.24% -65.40% +189.68% -30.63% -21.89% +57.71% +2.57% -35.78% +27.57% -2.25% +34.55% -27.26% +56.78% -23.28% -18.38% +2.12% +26.27% -46.31% +50.26% +0.73% -17.88% +24.70% -59.18% +40.60% -2.12% +5.01% +1.82% -29.50% +8.61% -4.33% -2.62% -26.31% n/a
Research and Development Revenue 829.61K 1.11M 1.27M 1.89M 1.19M 1.72M 1.17M 1.37M 1.05M 1.50M 1.22M 1.27M 1.38M 1.28M 999.27K 1.73M 1.80M 1.07M 740.58K 854.44K 1.23M 1.14M 998.96K 1.75M 874.55K 1.19M 705.27K 2.42M 1.28M 2.53M 2.66M 2.61M 3.90M 2.30M 3.98M
Research and Development Revenue Growth -25.01% -12.72% -32.94% +59.31% -31.18% +47.44% -14.80% +30.85% -29.99% +22.51% -3.81% -7.75% +7.51% +28.27% -42.09% -4.22% +68.27% +44.57% -13.33% -30.29% +7.27% +14.39% -42.86% +99.89% -26.25% +68.14% -70.87% +89.76% -49.47% -5.04% +2.01% -33.19% +69.88% -42.30% n/a

Create Price Alert on NAVB

Your price alert will notify you when the stock price is above 0.00.

Add to Watchlist